Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097469703> ?p ?o ?g. }
- W2097469703 endingPage "1269" @default.
- W2097469703 startingPage "1263" @default.
- W2097469703 abstract "Objective. Reduced work participation (WP) is a common problem for patients with rheumatoid arthritis (RA) and generates high costs for society. Therefore, it is important to explore determinants of WP at the start of tumor necrosis factor inhibitor (TNFi) treatment, and for changes in WP after 2 years of TNFi treatment. Methods. Within the Dutch Rheumatoid Arthritis Monitoring (DREAM) biologic register, WP data were available from 508 patients with RA younger than 65 years and without an (early) retirement pension. WP was registered at start of TNFi treatment and after 2 years of followup and was measured by single patient-reported binary questions whether they had work, paid or voluntary, or had a disability allowance or a retirement pension. Determinants measured at baseline were age, sex, disease duration, functional status [through Health Assessment Questionnaire-Disability Index (HAQ-DI)], 28-joint Disease Activity Score (DAS28), rheumatoid factor, presence of erosions, number of previous disease-modifying antirheumatic drugs, and number of comorbidities. During the 2 years of followup, HAQ-DI response and European League Against Rheumatism response were measured. Univariate analyses (excluded if p value was > 0.2) and multivariate (excluded if p value was > 0.1) logistic regression analyses were used. Results. Determinants associated with WP at baseline were having a better HAQ-DI (OR 0.32, p = 0.000) and male sex (OR 0.65, p = 0.065). After 2 years of TNFi therapy, 11.8% (n = 60) started to work and 13.6% (n = 69) stopped working. Determinants associated with starting to work were better baseline HAQ-DI (OR 0.58), positive RF (OR 2.73), and young age (OR 0.96); and for stopping work, worse baseline HAQ-DI (OR 2.74), low HAQ-DI response (OR 0.31), and comorbidity (OR 2.67), all with p < 0.1. Conclusion. Young patients with RA and a high functional status without any comorbidity will have a better chance of working. This supports the main goal in the management of RA: to suppress disease activity as soon and as completely as possible to prevent irreversible destruction of the joints, and thus maintain a good functional status of the patient. Because of the low proportion of variance explained by the models in this study, other factors besides the ones studied are associated with WP." @default.
- W2097469703 created "2016-06-24" @default.
- W2097469703 creator A5008395067 @default.
- W2097469703 creator A5012743754 @default.
- W2097469703 creator A5023478522 @default.
- W2097469703 creator A5044485746 @default.
- W2097469703 creator A5049538450 @default.
- W2097469703 creator A5076651742 @default.
- W2097469703 creator A5079792940 @default.
- W2097469703 creator A5082337435 @default.
- W2097469703 date "2014-05-15" @default.
- W2097469703 modified "2023-10-03" @default.
- W2097469703 title "Determinants Associated with Work Participation in Patients with Established Rheumatoid Arthritis Taking Tumor Necrosis Factor Inhibitors" @default.
- W2097469703 cites W1517231282 @default.
- W2097469703 cites W1985004174 @default.
- W2097469703 cites W1985763670 @default.
- W2097469703 cites W1986301068 @default.
- W2097469703 cites W1995228104 @default.
- W2097469703 cites W1999140069 @default.
- W2097469703 cites W2004153628 @default.
- W2097469703 cites W2016716920 @default.
- W2097469703 cites W2016849178 @default.
- W2097469703 cites W2041803731 @default.
- W2097469703 cites W2066409058 @default.
- W2097469703 cites W2081148269 @default.
- W2097469703 cites W2099885994 @default.
- W2097469703 cites W2102987799 @default.
- W2097469703 cites W2104482697 @default.
- W2097469703 cites W2107769196 @default.
- W2097469703 cites W2109799845 @default.
- W2097469703 cites W2110177517 @default.
- W2097469703 cites W2112753620 @default.
- W2097469703 cites W2113509034 @default.
- W2097469703 cites W2121969966 @default.
- W2097469703 cites W2122416803 @default.
- W2097469703 cites W2122921717 @default.
- W2097469703 cites W2124776843 @default.
- W2097469703 cites W2133778243 @default.
- W2097469703 cites W2146557322 @default.
- W2097469703 cites W2148201023 @default.
- W2097469703 cites W2148311007 @default.
- W2097469703 cites W2149598860 @default.
- W2097469703 cites W2152348310 @default.
- W2097469703 cites W2153732725 @default.
- W2097469703 cites W2162260707 @default.
- W2097469703 cites W2165087020 @default.
- W2097469703 cites W2314052274 @default.
- W2097469703 doi "https://doi.org/10.3899/jrheum.130878" @default.
- W2097469703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24833758" @default.
- W2097469703 hasPublicationYear "2014" @default.
- W2097469703 type Work @default.
- W2097469703 sameAs 2097469703 @default.
- W2097469703 citedByCount "8" @default.
- W2097469703 countsByYear W20974697032015 @default.
- W2097469703 countsByYear W20974697032018 @default.
- W2097469703 countsByYear W20974697032019 @default.
- W2097469703 countsByYear W20974697032020 @default.
- W2097469703 countsByYear W20974697032021 @default.
- W2097469703 countsByYear W20974697032023 @default.
- W2097469703 crossrefType "journal-article" @default.
- W2097469703 hasAuthorship W2097469703A5008395067 @default.
- W2097469703 hasAuthorship W2097469703A5012743754 @default.
- W2097469703 hasAuthorship W2097469703A5023478522 @default.
- W2097469703 hasAuthorship W2097469703A5044485746 @default.
- W2097469703 hasAuthorship W2097469703A5049538450 @default.
- W2097469703 hasAuthorship W2097469703A5076651742 @default.
- W2097469703 hasAuthorship W2097469703A5079792940 @default.
- W2097469703 hasAuthorship W2097469703A5082337435 @default.
- W2097469703 hasBestOaLocation W20974697031 @default.
- W2097469703 hasConcept C126322002 @default.
- W2097469703 hasConcept C144301174 @default.
- W2097469703 hasConcept C151956035 @default.
- W2097469703 hasConcept C1862650 @default.
- W2097469703 hasConcept C198451711 @default.
- W2097469703 hasConcept C2776232647 @default.
- W2097469703 hasConcept C2777077863 @default.
- W2097469703 hasConcept C2777489490 @default.
- W2097469703 hasConcept C2777575956 @default.
- W2097469703 hasConcept C2780289447 @default.
- W2097469703 hasConcept C2908647359 @default.
- W2097469703 hasConcept C38180746 @default.
- W2097469703 hasConcept C71924100 @default.
- W2097469703 hasConcept C99454951 @default.
- W2097469703 hasConceptScore W2097469703C126322002 @default.
- W2097469703 hasConceptScore W2097469703C144301174 @default.
- W2097469703 hasConceptScore W2097469703C151956035 @default.
- W2097469703 hasConceptScore W2097469703C1862650 @default.
- W2097469703 hasConceptScore W2097469703C198451711 @default.
- W2097469703 hasConceptScore W2097469703C2776232647 @default.
- W2097469703 hasConceptScore W2097469703C2777077863 @default.
- W2097469703 hasConceptScore W2097469703C2777489490 @default.
- W2097469703 hasConceptScore W2097469703C2777575956 @default.
- W2097469703 hasConceptScore W2097469703C2780289447 @default.
- W2097469703 hasConceptScore W2097469703C2908647359 @default.
- W2097469703 hasConceptScore W2097469703C38180746 @default.
- W2097469703 hasConceptScore W2097469703C71924100 @default.
- W2097469703 hasConceptScore W2097469703C99454951 @default.
- W2097469703 hasIssue "7" @default.